Back to Search Start Over

Derivation of the Pediatric Acute Gastroenteritis Risk Score to Predict Moderate-to-Severe Acute Gastroenteritis.

Authors :
Levine AC
O'Connell KJ
Schnadower D
VanBuren TJM
Mahajan P
Hurley KF
Tarr P
Olsen CS
Poonai N
Schuh S
Powell EC
Farion KJ
Sapien RE
Roskind CG
Rogers AJ
Bhatt S
Gouin S
Vance C
Freedman SB
Source :
Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2022 Apr 01; Vol. 74 (4), pp. 446-453. Date of Electronic Publication: 2022 Feb 03.
Publication Year :
2022

Abstract

Objectives: Although most acute gastroenteritis (AGE) episodes in children rapidly self-resolve, some children go on to experience more significant and prolonged illness. We sought to develop a prognostic score to identify children at risk of experiencing moderate-to-severe disease after an index emergency department (ED) visit.<br />Methods: Data were collected from a cohort of children 3 to 48 months of age diagnosed with AGE in 16 North American pediatric EDs. Moderate-to-severe AGE was defined as a Modified Vesikari Scale (MVS) score ≥9 during the 14-day post-ED visit. A clinical prognostic model was derived using multivariable logistic regression and converted into a simple risk score. The model's accuracy was assessed for moderate-to-severe AGE and several secondary outcomes.<br />Results: After their index ED visit, 19% (336/1770) of participants developed moderate-to-severe AGE. Patient age, number of vomiting episodes, dehydration status, prior ED visits, and intravenous rehydration were associated with MVS ≥9 in multivariable regression. Calibration of the prognostic model was strong with a P value of 0.77 by the Hosmer-Lemenshow goodness-of-fit test, and discrimination was moderate with an area under the receiver operator characteristic curve of 0.68 (95% confidence interval [CI] 0.65-0.72). Similarly, the model was shown to have good calibration when fit to the secondary outcomes of subsequent ED revisit, intravenous rehydration, or hospitalization within 72 hours after the index visit.<br />Conclusions: After external validation, this new risk score may provide clinicians with accurate prognostic insight into the likely disease course of children with AGE, informing disposition decisions, anticipatory guidance, and follow-up care.<br /> (Copyright © 2022 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.)

Details

Language :
English
ISSN :
1536-4801
Volume :
74
Issue :
4
Database :
MEDLINE
Journal :
Journal of pediatric gastroenterology and nutrition
Publication Type :
Academic Journal
Accession number :
35129163
Full Text :
https://doi.org/10.1097/MPG.0000000000003395